Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE IV, OPEN-LABEL STUDY OF THE ADHESION AND DERMAL TOLERABILITY OF EMSAM (SELEGILINE TRANSDERMAL SYSTEM) IN HEALTHY ADULT SUBJECTS OF TWO AGE GROUPS (18 - 64 YEARS, AND 65 YEARS AND OLDER)

NCT00531596 is registered in ClinicalTrials.gov with Somerset Pharmaceuticals as lead sponsor.

NCT NCT00531596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00531596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE IV, OPEN-LABEL STUDY OF THE ADHESION AND DERMAL TOLERABILITY OF EMSAM (SELEGILINE TRANSDERMAL SYSTEM) IN HEALTHY ADULT SUBJECTS OF TWO AGE GROUPS (18 - 64 YEARS, AND 65 YEARS AND OLDER)
Lead sponsor
Somerset Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
July 31, 2007
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy